Research News and Research

RSS

'Ultra Rice' piloted as way to tackle malnutrition

Ultra Rice, a rice-shaped pasta fortified with vitamins and minerals is "being produced and tested around the world as a potential solution to malnutrition," according to the Seattle Times. Produced by the nonprofit PATH, Ultra Rice is currently being piloted by the Indian and Brazilian governments in lunch programs and by the U.N. World Food Program in Cambodia. Each grain of Ultra Rice is combined with approximately 100 grains of ordinary rice.

27 Jul 2010

Epilepsy drugs analyzed for causing increased risk of suicide in patients

While the Food and Drug Administration requires a warning of an increased risk of suicide for all epilepsy drugs, a new study shows that only certain drugs may increase the risk. The study is published in the July 27, 2010, issue of Neurology, the medical journal of the American Academy of Neurology. Newer drugs with a higher risk of causing depression than other epilepsy drugs, such as levetiracetam, topiramate and vigabatrin, were found to increase the risk of self-harm or suicidal behavior among people with epilepsy.

27 Jul 2010

Alexza second-quarter net loss decreases to $12.9 million

Alexza Pharmaceuticals, Inc. today reported financial results for the quarter ended June 30, 2010 and provided a business update. The net loss for the three and six months ended June 30, 2010, as reported in accordance with accounting principles generally accepted in the United States (GAAP), was $12.9 million and $26.3 million, respectively, compared to a net loss of $17.0 million and $23.9 million in the respective comparable periods in 2009. Alexza had consolidated cash, cash equivalents and marketable securities at June 30, 2010 of $41.7 million.

27 Jul 2010

Americans with Disabilities Act turns 20

Several news outlets note the 20th anniversary Monday of the Americans With Disabilities Act.

27 Jul 2010

Scientists discover mechanism of herpes virus cell entry machinery

The mechanism by which a herpes virus invades cells has remained a mystery to scientists, but now research from Tufts University and the University of Pennsylvania reveals the unusual structure of a key member of the protein complex that allows a herpes virus to invade cells.The new map details an essential piece of the herpes virus "cell-entry machinery," providing scientists with a new target for antiviral drugs.

27 Jul 2010

Racial, ethnic disparities remain a challenge for patients in the U.S. health care system: ACP

Racial and ethnic disparities remain a challenge for patients in the U.S. health care system, the American College of Physicians said in an updated paper released today. Racial and Ethnic Disparities in Health Care, Updated 2010, an update to a policy paper that was originally released in 2003, outlines recommendations on how to close the gap between racial and ethnic minority patients and their white counterparts.

27 Jul 2010

Study analyses anesthetic effects on surgical site infections

A study appearing in the August 2010 issue of Anesthesiology found that patients receiving a total hip or knee replacement in Taiwan had a higher incidence of surgical site infections (SSIs) when general anesthesia was administered for the operation than when the same procedures were performed under epidural/spinal (regional) anesthesia.

27 Jul 2010

AIDS 2010 opinions: U.S. funding for global HIV/AIDS programs; Empowering women, girls in fight against HIV/AIDS

The first letter, Ambassador Eric Goosby, U.S. Global AIDS Coordinator, addresses an opinion piece by Desmond Tutu, archbishop emeritus of Cape Town and honorary chairman of the Global AIDS Alliance. Goosby writes, "The United States has been and continues to be the global leader on HIV/AIDS. The best metric of our success is lives saved." Goosby cites an increased number of people on antiretrovirals financed by the United States and a commitment to treat 4 million more as part of the Global Health Initiative.

27 Jul 2010

New drug for type 2 diabetes, Effect of insulin on bones

In a groundbreaking finding, a new medicine Galvus (vildagliptin) has been created for people with type 2 diabetes that would lower blood glucose levels without the side effects of other medications.

26 Jul 2010

Adventist Hinsdale Hospital, Marianjoy announce partnership

Patients with acute physical rehabilitation needs now can undergo inpatient treatment close to home thanks to a new partnership between Adventist Hinsdale Hospital and Marianjoy Rehabilitation Hospital. Announced today, the cooperative effort unites two organizations with similar holistic approaches to rehabilitative patient care for a variety of conditions in multiple settings.

26 Jul 2010

Bill giving malpractice coverage to doctors volunteering in community health centers faces stiff Senate resistance

The Hill: A bill aimed to appeal to physicians to work in medically underserved areas by shielding them from paying for malpractice coverage is facing stiff opposition. "The bill, passed Thursday by the House Energy and Commerce Health subcommittee, would offer free malpractice coverage to doctors volunteering at community health centers (CHCs) — private facilities receiving federal funds to treat patients where care is lacking."

26 Jul 2010

CPC partners with CU School of Medicine on stem cell research

A major research company with expertise in managing clinical trials is partnering with the University of Colorado's Anschutz Medical Campus to more efficiently bring the latest stem cell discoveries from the laboratory to the patient.

26 Jul 2010

Seaside Therapeutics reports positive data from STX209 Phase 2 study in fragile X syndrome

Seaside Therapeutics, Inc. announced today data from the largest randomized, placebo-controlled study conducted to date in individuals with fragile X syndrome. In a Phase 2 study of STX209, clinically meaningful improvements on global and specific neurobehavioral outcomes were observed in the general study population. The improvements were statistically significant in pediatric patients with more severe impairments in sociability -- a core symptom of fragile X syndrome.

26 Jul 2010

Hospira commences EPO Phase I U.S. clinical trial in renal dysfunction patients with anemia

Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced the start of a U.S. Phase I clinical trial of its biosimilar erythropoietin (EPO) in patients with renal (kidney) dysfunction who have anemia, an important step on the road toward introducing a biosimilar product in the United States. Erythropoietin is a treatment for anemia associated with chronic renal failure and chemotherapy.

26 Jul 2010

QPS acquires Xendo Drug Development

QPS Holdings, LLC, a leading full-service GLP/GCP-compliant contract research organization providing testing services to support preclinical and clinical research and development, announced the completion of its acquisition of Xendo Drug Development BV (XDD), headquartered in Groningen, The Netherlands. XDD, a European contract research organization (CRO), will be known as QPS Netherlands BV and become a wholly-owned subsidiary of QPS Holdings, LLC.

26 Jul 2010

Today's OpEds: Health reform and long-term care; Health care incentives; Reasons for optimism or repeal and replace?

Our system of long-term care does not provide adequate or coordinated human services and medical treatment for our growing aging population. … Thanks to a provision of the new health care law known as the Community Living Assistance Services and Supports program, tomorrow's continuum of care does not have to be so unforgiving. For the first time, a voluntary public insurance program will be available to help adults and families pay for long-term care services (Bruce Chernof, 7/23).

26 Jul 2010

Obesity linked to early puberty in girls

A review of more than 100 studies found overweight girls tend to reach puberty earlier than their peers do.

26 Jul 2010

KHN column: Where are the innovators in health care delivery?

In his latest Kaiser Health News column, John Goodman writes: "Almost everyone believes there is an enormous amount of waste and inefficiency in health care.

26 Jul 2010

Calibra Medical's Finesse insulin patch-pen receives FDA clearance for use with Novo Nordisk's Novolog

Calibra Medical announced today it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Finesse™ insulin patch-pen for up to three-day use with Novo Nordisk's Novolog® rapid acting insulin. Combining the mealtime therapy-adherence benefits of insulin pumps with the simplicity and affordability of syringes and pens, Calibra's novel bolus-only patch-pen is a small, adhesively attached, flat device that can be operated discretely through clothing to deliver mealtime, snack time, and correction bolus insulin in seconds.

26 Jul 2010

Intuit combines Medfusion with Quicken Health Group

Intuit Inc. has transformed its healthcare business by combining newly acquired Medfusion with its Quicken Health Group to create a new business unit called Intuit Health. Based in Cary, N.C., the group is committed to improving healthcare through innovative online connected services that make the clinical, administrative, and financial side of healthcare easier for everyone.

26 Jul 2010

Research News and Research

'Ultra Rice' piloted as way to tackle malnutrition

Epilepsy drugs analyzed for causing increased risk of suicide in patients

Alexza second-quarter net loss decreases to $12.9 million

Americans with Disabilities Act turns 20

Scientists discover mechanism of herpes virus cell entry machinery

Racial, ethnic disparities remain a challenge for patients in the U.S. health care system: ACP

Study analyses anesthetic effects on surgical site infections

AIDS 2010 opinions: U.S. funding for global HIV/AIDS programs; Empowering women, girls in fight against HIV/AIDS

New drug for type 2 diabetes, Effect of insulin on bones

Adventist Hinsdale Hospital, Marianjoy announce partnership

Bill giving malpractice coverage to doctors volunteering in community health centers faces stiff Senate resistance

CPC partners with CU School of Medicine on stem cell research

Seaside Therapeutics reports positive data from STX209 Phase 2 study in fragile X syndrome

Hospira commences EPO Phase I U.S. clinical trial in renal dysfunction patients with anemia

QPS acquires Xendo Drug Development

Today's OpEds: Health reform and long-term care; Health care incentives; Reasons for optimism or repeal and replace?

Obesity linked to early puberty in girls

KHN column: Where are the innovators in health care delivery?

Calibra Medical's Finesse insulin patch-pen receives FDA clearance for use with Novo Nordisk's Novolog

Intuit combines Medfusion with Quicken Health Group

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence